Cargando…

Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial

Background: Migraine is a common neurological disorder, and it is the second leading cause of disability worldwide. Manual techniques based on physical therapy have been proposed to improve migraine aspects; however, further research is needed on their effectiveness. The aim of this study was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Gómez, Elena, Inglés, Marta, Aguilar-Rodríguez, Marta, Mollà-Casanova, Sara, Sempere-Rubio, Núria, Serra-Añó, Pilar, Espí-López, Gemma V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836770/
https://www.ncbi.nlm.nih.gov/pubmed/35160211
http://dx.doi.org/10.3390/jcm11030759
_version_ 1784649759160532992
author Muñoz-Gómez, Elena
Inglés, Marta
Aguilar-Rodríguez, Marta
Mollà-Casanova, Sara
Sempere-Rubio, Núria
Serra-Añó, Pilar
Espí-López, Gemma V.
author_facet Muñoz-Gómez, Elena
Inglés, Marta
Aguilar-Rodríguez, Marta
Mollà-Casanova, Sara
Sempere-Rubio, Núria
Serra-Añó, Pilar
Espí-López, Gemma V.
author_sort Muñoz-Gómez, Elena
collection PubMed
description Background: Migraine is a common neurological disorder, and it is the second leading cause of disability worldwide. Manual techniques based on physical therapy have been proposed to improve migraine aspects; however, further research is needed on their effectiveness. The aim of this study was to evaluate the effectiveness of a craniosacral therapy protocol on different features in migraine patients. Methods: Fifty individuals with migraine were randomly divided into two groups (n = 25 per group): (i) craniosacral therapy group (CTG), following a craniosacral therapy protocol, and (ii) sham control group (SCG), with a sham treatment. The analyzed variables were pain, migraine severity and frequency of episodes, functional, emotional, and overall disability, medication intake, and self-reported perceived changes, at baseline, after a 4 week intervention, and at 8 week follow-up. Results: After the intervention, the CTG significantly reduced pain (p = 0.01), frequency of episodes (p = 0.001), functional (p = 0.001) and overall disability (p = 0.02), and medication intake (p = 0.01), as well as led to a significantly higher self-reported perception of change (p = 0.01), when compared to SCG. In addition, the results were maintained at follow-up evaluation in all variables. Conclusions: A protocol based on craniosacral therapy is effective in improving pain, frequency of episodes, functional and overall disability, and medication intake in migraineurs. This protocol may be considered as a therapeutic approach in migraine patients.
format Online
Article
Text
id pubmed-8836770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88367702022-02-12 Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial Muñoz-Gómez, Elena Inglés, Marta Aguilar-Rodríguez, Marta Mollà-Casanova, Sara Sempere-Rubio, Núria Serra-Añó, Pilar Espí-López, Gemma V. J Clin Med Article Background: Migraine is a common neurological disorder, and it is the second leading cause of disability worldwide. Manual techniques based on physical therapy have been proposed to improve migraine aspects; however, further research is needed on their effectiveness. The aim of this study was to evaluate the effectiveness of a craniosacral therapy protocol on different features in migraine patients. Methods: Fifty individuals with migraine were randomly divided into two groups (n = 25 per group): (i) craniosacral therapy group (CTG), following a craniosacral therapy protocol, and (ii) sham control group (SCG), with a sham treatment. The analyzed variables were pain, migraine severity and frequency of episodes, functional, emotional, and overall disability, medication intake, and self-reported perceived changes, at baseline, after a 4 week intervention, and at 8 week follow-up. Results: After the intervention, the CTG significantly reduced pain (p = 0.01), frequency of episodes (p = 0.001), functional (p = 0.001) and overall disability (p = 0.02), and medication intake (p = 0.01), as well as led to a significantly higher self-reported perception of change (p = 0.01), when compared to SCG. In addition, the results were maintained at follow-up evaluation in all variables. Conclusions: A protocol based on craniosacral therapy is effective in improving pain, frequency of episodes, functional and overall disability, and medication intake in migraineurs. This protocol may be considered as a therapeutic approach in migraine patients. MDPI 2022-01-30 /pmc/articles/PMC8836770/ /pubmed/35160211 http://dx.doi.org/10.3390/jcm11030759 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Muñoz-Gómez, Elena
Inglés, Marta
Aguilar-Rodríguez, Marta
Mollà-Casanova, Sara
Sempere-Rubio, Núria
Serra-Añó, Pilar
Espí-López, Gemma V.
Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title_full Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title_fullStr Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title_full_unstemmed Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title_short Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial
title_sort effect of a craniosacral therapy protocol in people with migraine: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836770/
https://www.ncbi.nlm.nih.gov/pubmed/35160211
http://dx.doi.org/10.3390/jcm11030759
work_keys_str_mv AT munozgomezelena effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT inglesmarta effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT aguilarrodriguezmarta effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT mollacasanovasara effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT sempererubionuria effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT serraanopilar effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial
AT espilopezgemmav effectofacraniosacraltherapyprotocolinpeoplewithmigrainearandomizedcontrolledtrial